Go Symbol Lookup
Loading...

Akzo Nobel NV

More

  • RESEARCH ALERT-Akzo Nobel : UBS cuts price target Monday, 29 Apr 2013 | 4:54 AM ET

    April 29- Akzo Nobel NV:. *UBS cuts price target to 41 euros from 44 euros; rating sell. For a summary of rating actions and price target changes on European companies: Reuters Eikon users, click on RCH/ EUROPE Reuters 3000 Xtra users, double-click RCH/ EUROPE Reuters Station users, click. 1580.

  • RESEARCH ALERT-Akzo Nobel: Commerzbank cuts to hold Thursday, 25 Apr 2013 | 3:40 AM ET

    April 25- Akzo Nobel NV:. *Commerzbank cuts to hold from buy; cuts price target to 51 euros from 65. Reuters Station users, click. 1580.

  • *Iraq says companies conspired with Saddam Hussein regime. District Judge Sidney Stein in Manhattan said the government of Iraq could not recover damages and other remedies under a U.S. anti-racketeering law because most of the wrongful conduct took place in foreign countries.

  • Europe Close Lower as Investors Lock in Profits Friday, 14 Dec 2012 | 11:36 AM ET

    European shares closed slightly lower on Friday as investors locked in profits ahead of the weekend and once again focused on the ongoing discussions surrounding the "fiscal cliff" in the U.S.

  • Early Movers: ADBE, FB, PAY & More Friday, 14 Dec 2012 | 8:10 AM ET

    Some of the names on the move ahead of the open.

  • European shares steady as Akzo and Daimler rise Friday, 14 Dec 2012 | 7:08 AM ET

    *Akzo Nobel and Daimler among top gainers. *Rise in China manufacturing boosts sentiment for equities. LONDON, Dec 14- European shares steadied near 18- month highs on Friday, lifted by chemicals group AkzoNobel and carmaker Daimler, and many traders expected a further gradual rise before the year-end.

  • The boss of paint maker Akzo Nobel has told CNBC he is "excited to be back" after his temporary departure from the firm and has revealed the U.S. arm of the business will be sold off to focus on Europe and high growth markets.

  • Ton Büchner, CEO of Akzo Nobel, tells CNBC that the company is selling its US operations as it lacks critical mass in North America and would require significant additional funding to be profitable.